Atomwise, which develops a machine learning-based drug discovery service, raises $123M Series B led by B Capital and Sanabil Investments (Jonathan Shieber/TechCrunch)

Jonathan Shieber / TechCrunch:
Atomwise, which develops a machine learning-based drug discovery service, raises $123M Series B led by B Capital and Sanabil Investments  —  With a slew of partnerships with large pharmaceutical companies under its belt and the successful spin out of at least one new company …